Life sciences software & AI news

Daily news on AI, software, and digital tools for pharma, biotech, CROs, and life sciences research labs.

Showing 1000+ results
A medical chart on a table in a busy hospital corridor

Jul 22, 2026

BMC plans AI-powered diagnostics, smart OPDs, and online bed allocation to overhaul civic healthcare in M

The Brihanmumbai Municipal Corporation (BMC) is set to implement a comprehensive modernization plan for its public healthcare system, incorporating advanced technologies like AI and online services.The BMC's initiative outlines a three-phase strategy aimed at enhancing civic healthcare in Mumbai. In the initial phase, the focus will be on establishing smart digital outpatient departments (OPDs) to minimize patient waiting times and improve hospital management through a centralized monitoring das
A flat illustration of a robotic arm and surgical device in a minimalist style.

Jul 22, 2026

Tech Trends 2026: A life sciences perspective

As we look toward 2026, several key AI trends are poised to significantly influence the life sciences sector, particularly in biopharma and medtech.The evolution of embodied AI is transforming robotic systems from basic automation to adaptive entities capable of perception and autonomous operation. This advancement is particularly notable in sterile manufacturing within biopharma and in the development of sophisticated surgical devices in medtech. However, the widespread implementation of these
A minimalist illustration of a generic drug pill against a solid background.

Jul 22, 2026

Proposed US tariffs on generic drugs unfeasible for Indian manufacturers, say pharma leaders

Indian pharmaceutical leaders are expressing significant concerns regarding the proposed US tariffs on generic drugs, which could rise to 200% within a few years, deeming them unmanageable for manufacturers operating on tight margins.Recently, US President Donald Trump outlined a tariff plan that would initially impose zero tariffs on generic drugs imported into the US for two years, followed by a gradual increase to 100% in the third year and 200% from the fourth year onward. This initiative ai
Minimalist illustration of a vehicle with a sensor icon, representing AI diagnostics.

Jul 22, 2026

The Rise of AI-Powered Vehicle Diagnostics

AI is revolutionizing vehicle diagnostics, enhancing reliability and maintenance through real-time data analysis.Artificial intelligence is significantly transforming vehicle diagnostics by utilizing extensive data generated from a vehicle's onboard sensors and systems. Unlike traditional diagnostics that rely on warning lights and fault codes, AI continuously monitors vehicle performance, identifying potential issues before they escalate into major repairs. This proactive approach improves reli
A microcentrifuge tube with a biological sample in a lab setting

Jul 22, 2026

SITC Announces EU Immuno-oncology Drug Development Summit - Bringing the European IO Community Together to Foster the Next Wave of IO Therapeutics

The Society for Immunotherapy of Cancer (SITC) is set to host the EU Immuno-oncology Drug Development Summit in Lausanne, Switzerland, on September 3–4, 2026. This event aims to unite key players in the immuno-oncology field, including regulatory bodies, biotech firms, and academic researchers, to enhance collaboration and share best practices in drug development.The summit will feature a keynote address by Dr. E. John Wherry, focusing on the intersection of immuno-oncology and autoimmunity. Org
Flat design of a map silhouette representing state outlines for AI legislation

Jul 22, 2026

Interactive Map of Enacted State AI Laws & Bills

Epstein Becker Green has introduced an interactive map designed to help navigate the evolving landscape of state-level artificial intelligence (AI) legislation in the United States. This tool is particularly valuable for organizations in the healthcare and life sciences sectors, as it outlines the varying compliance requirements across different states.As of now, 28 states have enacted laws regulating AI, particularly in areas such as healthcare, employment, and broader industry applications. Th
A biotech startup brochure and laboratory notebook on a desk in a dimly lit office.

Jul 22, 2026

Revvity to Launch Signals for Startups for Emerging Biotech Companies

Revvity, Inc. is set to launch Signals for Startups, a new initiative aimed at supporting early-stage biotech companies in establishing scalable digital informatics capabilities. This program is anticipated to roll out in late July 2026 across various regions, including the U.S., Europe, the Middle East, and Africa.The Signals for Startups program offers access to enterprise-grade Signals software, tailored onboarding, and flexible licensing options designed specifically for the needs of emergin
Flat design of a coin and calculator representing investment and analysis

Jul 22, 2026

The AI Investment Paradox: Asset Managers Divided Over Whether They Are Spending Too Much or Too Little, Global Research Reveals

Recent research from Clearwater Analytics highlights a significant divide among asset managers regarding AI investment strategies, revealing a paradox in the industry. While 63% of firms have increased their AI budgets by over 50% in the last year, 66% of fund managers express concerns about over-investment, whereas 25% feel they are not investing enough.This research indicates that AI integration in asset management is more advanced than previously thought, with 56% of managers having adopted A
Petri dish with cultured human cells in a dim laboratory setting

Jul 22, 2026

The biotech bi-weekly: multiomics, human cell-based research, next-gen cell recovery and biomarker development

This week in biotech highlights significant advancements in multiomics, human cell research, and innovative production methods involving microbes.Novogene Europe has bolstered its multiomics capabilities with the launch of an Untargeted Metabolomics Service at its Cambridge Omics Centre. This service aims to enhance the understanding of molecular interactions by integrating metabolomic data with genomics and other life sciences, providing researchers with deeper insights into biological function
A minimalist illustration of a pill and a digital health symbol on a dark background.

Jul 22, 2026

BRICS Health Push: Can India’s Pharma, Digital Health And AI Firms Benefit?

India is positioning itself to leverage its pharmaceutical and digital health sectors within the BRICS framework, emphasizing innovation and regulatory cooperation as key to unlocking new market opportunities.As India prepares to host the BRICS Health Ministers’ Meeting in Chandigarh, the focus is shifting from traditional public health to integrating digital health, AI, and pharmaceutical innovation. This shift raises the question of whether these discussions can translate into tangible benefit
A stethoscope on a wooden table in a clinical room, with a medical chart in the background.

Jul 22, 2026

Regulation, Data, and Digital Health: Why Ireland Is Emerging as a Hub for SaMD and EU Health Data Innovation

The landscape of digital health is evolving in Ireland, positioning the country as a promising hub for Software-as-a-Medical-Device (SaMD) and health data innovation. Recent regulatory advancements have shifted the relationship between regulation and technology from adversarial to collaborative, fostering an environment ripe for innovation.SaMD encompasses software that operates independently to perform medical functions, including AI diagnostics and clinical support. As regulations like the Med
A wearable biosensor on a patient's skin in a clinical setting.

Jul 22, 2026

Trinity Biotech's Wearable Sensors May Guide Drug Delivery

Trinity Biotech has entered a strategic partnership with Latch Medical to enhance drug delivery through innovative biosensor technology.The collaboration aims to integrate Trinity Biotech's CGM+ wearable biosensor platform with Latch Medical's intradermal drug delivery system, Pharma Latch™. This partnership seeks to leverage real-time metabolic data for more personalized therapeutic interventions in managing diabetes, obesity, and other metabolic disorders. By combining advanced biosensing with